Alkermes Education Grants


Grant amount: Unspecified amount

Deadline: Rolling

Applicant type: Indigenous Group Government Entity College / University Nonprofit

Funding uses: Education / Outreach

Location of project: United States

Location of residency: United States

View website    Save Need help writing this grant?


Alkermes Education Grants

Alkermes contributes to independent education by supporting educational grants. Our focus areas include educational activities with pragmatic approaches to improve patient care and public health in the domains of schizophrenia, depression, and alcohol and opioid dependence. We expect to contribute to a better and expanded understanding of the underlying mechanisms of disease and their relevance to medications that address those characteristics, as well as the overall treatment in a broad sense that includes psychosocial methods. Grant requests must be unsolicited, should typically have multiple funders, support education on a wide range of treatment options, not promote a particular medicine and must not provide nor promise to Alkermes any tangible benefit.

Educational Requests: Support for independent medical and scientific education programs or activities focused on substance abuse, opioid dependence, alcohol dependence, and mental & behavioral health, including funding for educational conferences, seminars, meetings, other live events, and presentations in other formats such as Internet-based presentations and publications.

Areas of Interest

Substance Use Disorders

  • Reducing barriers to the treatment of substance use disorders
  • Increasing awareness of addiction treatment guidelines and policies
  • Understanding medication-assisted treatment options
  • Transitioning between levels of care for medication-assisted treatment
  • Treatment of special populations, including:
    • Criminal justice
    • Young adults


  • The role of Long-Acting Injectables (LAIs) across the lifespan of schizophrenia
  • Enhancement of patient care in schizophrenia
  • Psychopharmacology of LAIs (PK/PD)
  • The role of LAIs in managing gaps in transitions of care
  • Managing co-occurring illnesses (e.g., schizophrenia and substance use disorder)
  • Evaluate clinical decision models for treatment and continued management of schizophrenia

Major Depression Disorder (MDD)

  • Neurobiology/pharmacology of MDD disease
  • Methods for treatment-resistant depression
  • Exploring existing and novel (e.g., non-monoamine) pharmacological mechanisms of MDD
  • Mood disorders and the role of endogenous opioid system

You can learn more about this opportunity by visiting the funder's website.


  • Qualified organizations for U.S. Medical Educational requests are those that provide educational opportunities for physicians and other health care professionals.
  • The organizations are responsible for the content, quality, and scientific integrity of all activities they certify for credit.


  • Alkermes U.S. Medical Education will consider proposals for educational activities from non-accredited organizations; however, accredited programs will receive the highest priority.


  • Alkermes’ educational grant funds may not be used to support overhead expenses of the applicant or for any other institution affiliated with the applicant.
  • Education grants will not be awarded to or for:
    • Individuals or a healthcare professional’s private practice
    • Any charity or foundation associated with or controlled by an individual healthcare professional or healthcare professional’s private practice
    • Organizations that discriminate on the basis of race, color, sex, sexual orientation, religion, age, national origin or disability
    • Fundraising event of a potential customer (e.g., treatment center or hospital) where the proceeds are being used to cover general operational and routine business costs
    • Events that have already occurred
    • Political organizations, campaigns and activities
    • Religious organizations or groups whose activities are primarily sectarian in purpose
    • Programs or proposals that supplement an organization’s income or offset its expenses in a manner that benefits, directly or indirectly, a physician’s compensation
  • Alkermes does not provide support for education programs that are intended to encourage, induce, or influence any grant recipient to purchase, prescribe, refer, recommend, sell, administer, or arrange for the purchase, sale or recommendation, or formulary placement of any Alkermes’ product.